A global pharmaceutical group rebaselined its Ariba estate, removed three SLP add-ons that were never deployed, and renewed at sixty-four per cent below the proposed value.
Every result on this site is anonymised at the client's request. Specific figures are real and verifiable through a confidentiality-protected reference call arranged on request.
The client is a global pharmaceutical company with operations across the United States, the European Union, and India, with combined revenue near eleven billion dollars. Ariba had been the primary procurement platform since 2018, with Sourcing, the Network, and Supplier Lifecycle and Performance Management all in production.
The renewal proposal arrived with a three point nine million dollar annual value, citing supplier-base growth and the maturation of supplier-management workflows as the principal drivers. The proposal included three SLP add-on modules and a Network re-tier.
The chief procurement officer asked for an independent renewal review. The category-management workflow had matured, but the procurement function had not validated which of the proposed modules were actually in use.
SAP's opening proposal included the core Ariba Sourcing renewal, a Network re-tier on the basis of supplier-base growth from eight thousand to twelve thousand eight hundred active suppliers, and the addition of three Supplier Lifecycle and Performance Management add-on modules: risk monitoring, segmentation, and performance scorecards.
The three SLP add-ons were positioned as essential for pharmaceutical supplier governance, with regulatory rationale cited around supplier-risk monitoring and quality assurance. The headline addition for the three modules was approximately eight hundred and forty thousand dollars per year.
The proposal carried a five-year forward commitment with a modernisation credit linked to the term.
We pulled deployment evidence for each of the three proposed SLP modules. Two of the three — segmentation and performance scorecards — were not deployed in any meaningful way; the small group of users active in those modules numbered fewer than a dozen and were trial-only. The two modules were removed from the renewal in full.
The risk-monitoring module had genuine clinical-supplier use, but the proposed scope covered all twelve thousand eight hundred suppliers. We narrowed the scope to the regulated subset of approximately three thousand two hundred suppliers, reducing the module fee by more than half.
The Network re-tier was based on raw supplier-count growth. The document-volume evidence showed that approximately forty per cent of the new suppliers were sub-threshold transactors. The legitimate tier change was modest.
The modernisation credit was repositioned as a one-time renewal incentive applied to the first year, with no requirement to commit to a five-year term.
The five-year term was reduced to three years with a written option to re-bid the supplier-management modules at the end of the term against third-party alternatives.
Settlement closed at one point four million dollars per year, against an opening of three point nine. The reduction was approximately sixty-four per cent on the renewal proposal. The two unused SLP modules were removed; the risk-monitoring scope was narrowed; the Network re-tier was reduced; and the term was shortened from five years to three.
Total contracted value over the three-year term came in approximately seven point eight million dollars below the proposed five-year value, with a clean re-bid right on the supplier-management capability at the end of the term.
The procurement function retained the supplier-risk capability that mattered for regulatory purposes, without paying for two modules it had never deployed.
Two of the three SLP modules had a handful of trial users. They had been on the renewal list for two cycles before anyone asked whether they were used.
Buyer-side renewal negotiation with clause-by-clause review of the master, schedule, and every add-on module proposed.
Read the brief →Deployment evidence, utilisation audit, and a clean baseline before any renewal conversation begins.
Read the brief →The dedicated topic page covering licensing structure, audit exposure, and the negotiation playbook for SAP Ariba.
The twelve renewal levers and the contract language we draft into every master.
How SLP, segmentation, and scorecards are licensed, and which add-ons rarely deploy.
A global consumer-goods group reduced an Ariba renewal from $5.4M to $2.1M and removed an indexation clause.
A professional-services firm restructured a Guided Buying renewal and removed two unused modules.
Browse the complete library of anonymised SAP audit, renewal, and indirect-access defence engagements.
An audit notification, a renewal proposal, or a contract clause that does not read clearly — the first conversation is at no cost and under privilege. Forty years of buyer-side SAP experience, $180M+ in client savings, 500+ engagements.
Contact Us →Every Wednesday. Field reports from active matters, decoded SAP communications, and what to look for in the next audit cycle. Work email only.